Lenard Adler, MD, explains how clinicians can safely and effectively treat ADHD when bipolar disorder and addiction are also in the picture. He addresses how to distinguish chronic ADHD symptoms from episodic mood disorders, why bipolar disorder is often missed in adults referred for depression or attention problems, and how substance use complicates both diagnosis and medication selection.
Dr. Adler also shares guidance on identifying red flags for diversion or misuse, setting appropriate expectations for medication trials, and navigating the limits of current treatment guidelines. The episode closes with a look toward emerging directions in ADHD treatment, including research on emotional dysregulation, executive function deficits, and next-generation neurofeedback approaches.
Lenard Adler, MD, is Pottash Professor of Psychiatry and Director of the Adult ADHD Program at NYU Langone Health
00:00 Why ADHD, Bipolar Disorder, and Addiction Must Be Treated Together 01:02 What Makes These ADHD Cases So Difficult 02:05 ADHD vs. Bipolar Disorder: Key Diagnostic Distinctions 04:43 The Link Between ADHD and Addiction 05:53 Using Stimulants Safely When Substance Use Is a Concern 07:57 Choosing Stimulants vs. Non-Stimulants 10:07 How Severity and Comorbidity Shape Treatment Decisions 12:06 The Limits of Guidelines and Biomarkers in ADHD Care 15:34 Executive Function and Emotional Dysregulation 16:13 Where ADHD Treatment Is Headed Next
This episode is intended for psychiatrists, mental health clinicians, and others interested in complex adult ADHD presentations.
This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care.
Podden och tillhörande omslagsbild på den här sidan tillhör
NYU Langone Health Department of Psychiatry. Innehållet i podden är skapat av NYU Langone Health Department of Psychiatry och inte av,
eller tillsammans med, Poddtoppen.